Browse hierarchy: [Hematology (HE)](/submissions/HE) → [Subpart A](/submissions/HE/subpart-a%E2%80%94) → [21 CFR 660.50](/submissions/HE/subpart-a%E2%80%94/660.50) → QHS — Anti-Human Globulin

# QHS · Anti-Human Globulin

_Hematology · 21 CFR 660.50 · Class U_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-a%E2%80%94/QHS

## Overview

- **Product Code:** QHS
- **Device Name:** Anti-Human Globulin
- **Regulation:** [21 CFR 660.50](/submissions/HE/subpart-a%E2%80%94/660.50)
- **Device Class:** U
- **Review Panel:** [Hematology](/submissions/HE)

## Identification

The proper name of this product shall be Anti-Human Globulin which shall consist of one or more antiglobulin antibodies identified in § 660.55(a)(4). The source of this product shall be either serum from animals immunized with one or more human serum globulins or protein-rich fluids derived from stable immunoglobulin-secreting cell lines maintained either in tissue cultures or in secondary hosts.

## Recent Cleared Devices (0 of 0)

_No cleared devices on record._

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-a%E2%80%94/QHS](https://fda.innolitics.com/submissions/HE/subpart-a%E2%80%94/QHS)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com